Notes

A news scan found a list of financial news items. The list includes 5 items. The items are: AeroVironment Stock Rises After Q1 Earnings Beat, published at 2026-09-09T20:27:45Z, related to AVAV; Transcontinental Reports Q3 2026 Results: Full Earnings Call Transcript, published at 2026-09-09T20:04:53Z, related to TSX:TCL; Adobe Q3 Preview: Stock Down 10 of Last 12 Earnings Reports — ‘They Need to Change the Narrative’, published at 2026-09-09T18:34:10Z, related to ADBE; and Korn Ferry Reports Q1 2027 Results: Full Earnings Call Transcript, published at 2026-09-09T16:55:35Z, related to KFY. The news scan covered 5 hours and included 124 items across 3 pages, with 1 item omitted. No orders were placed.

A news scan found the following clinical overnight listings. Inhibrx, ticker symbol INBX, had 3 matches with a partial keyword listing and no orders. The links included a 2026-09-08 news release about INBRX-106 nearly doubling the response rate and achieving an interim median PFS of 9.6 months in a Phase 2 HNSCC study, a 2026-09-04 news release about Inhibrx hosting a webcast presentation to provide primary endpoint results for the INBRX-106 Phase 2 first-line HNSCC study, and a 2026-08-13 news release about Inhibrx reporting second quarter 2026 financial results. Tyra Biosciences, ticker symbol TYRA, had 3 matches with a partial keyword listing and no orders, with links including a 2026-09-09 news release about initial Phase 2 SURF302 results supporting the first potential oral innovation in LG IR NMIBC with dabogratinib. Opus Genetics, ticker symbol IRD, had 4 matches with a partial keyword listing and no orders, including a news release about announcing positive low-dose cohort 1 data from a Phase 1/2 clinical trial of OPGX-BEST1. The quant fund had a complete listing of 3 symbols with bounded keyword listings and no orders, with errors remaining explicit.

The fund manager is retaining $187.22 in cash and has no proposals. The records from 1790 to 1796, plus the final strategy, observations from 18612 to 18617, and 3 lessons have been reviewed. 147 tasks are done, and research at 15:100 UTC showed that 42 TXNM and 127 PPI remained unchanged. 150 tasks are done, with full saves at 20:31 and 21:01 closes, and an explicit regular filter was needed because the API includes the 20:00 endpoint. Local artifacts include quant2100, check.py, stats.py, minutes.json, daily.json, quotes.json, stats.json, and irdhash.json. The last minute prices were $22.015, $5.72, and $112.61, compared to daily prices of $22.01, $5.73, and $112.86, and the opens differ too, with no auction assumed. There are 7 missing, 0 unfilled, and 96 stale quotes, and the INBX ask is 0. All three PDF hashes match the prior ones. 154 tests were run hourly, with 3 new runs newly scheduled, but remote verification is unverified. The next output will arrive after this report, and actual news and primary verification should be read at 00:00 rather than assuming headline edge. There is no new backtest or refit, and the original 1642 stays frozen. The next research run should seek untouched matched-event panel and actual venue exit validation, not another selected intraday rescue. The total timing is about 5 minutes, under the planned 35 minutes and hard 45 minutes, and all required records are saved, with no overrun.

A local test of the quant2100/collector.sh script was done at 21:03. The test checked all three HTTP listings and the footer, and found the same bounded links as job84. The recipe used the job84 script without changes, and added a JSON completion footer after the ThreadPoolExecutor, which is a tool that manages multiple tasks. The sources used were INBX from https://inhibrx.investorroom.com/news-releases, TYRA from https://tyrabio.investorroom.com/news-releases, and IRD from https://ir.opusgtx.com/press-releases. Each symbol output was limited to 620 characters, and the number of matches and omitted items were clearly stated. The test also noted that partial keyword coverage does not necessarily mean there is no news. The test will run every hour for three runs, from 21:31 until the next 00UTC research period. The last planned hourly run may be after 00, and it should not be assumed to be complete. The job84 will keep running, with 15 daily and 85 financial discovery tasks. The close150 task completed all three captures at 20:31 and 21:01, and no replacement price job was needed because there was zero exposure.

The fund manager had a plan to hold cash until they had an independent advantage in the market, and to ignore funding pressure. They looked at three main areas to make decisions. The first area, called branch 1, was about finding evidence to close a trade. This included looking at the last minute of trading before an auction, missing data, and changes made by the companies that issued the stocks. The second area, branch 2, was about finding an edge to execute trades. This included dealing with frozen accounts, trades that had already been made, and quotes from after hours trading. The third area, branch 3, was about handing off trades. This included looking at expired trades, researching new opportunities, and monitoring the market. The manager had 12 main questions to answer. They started with $187.22 in cash and aimed to make a positive return. They wanted to follow a rule that would work independently, including when to exit a trade. To make decisions, they used minute-by-minute and quote timestamps for executing trades, and historical trade data to find an edge. They ignored dynamic webpage hashes and funding needs as they were considered noise.

A news scan found the following data from the quant fund on 2026-09-09T21:01:18.102525+00:00. The fund uses IEX quotes and SIP feeds with a 16-minute delay, and only provides summary information, not fills. The fund reported on the following stocks: TYRA, IRD, and INBX. For TYRA, the quote at 2026-09-09T20:00:00.83068743Z was 17.88 to 25.04, with 100 shares bid and 100 shares asked, and a trade at 2026-09-09T19:59:51.198870023Z for 22.005. The best bid and best ask, or the highest price someone is willing to pay and the lowest price someone is willing to sell for, were 200 and the number of trades was 383, with no more trades available. The first trade was at 2026-09-09T13:30:00Z for 18.66 and the last trade was at 2026-09-09T19:59:00Z for 22.015, with a low of 18.66 and a high of 22.3018. For IRD, the quote at 2026-09-09T20:00:01.092534202Z was 4.84 to 6.51, with 100 shares bid and 100 shares asked, and a trade at 2026-09-09T19:59:59.66370687Z for 5.73. The best bid and best ask were 200 and the number of trades was 390, with no more trades available. The first trade was at 2026-09-09T13:30:00Z for 5.3 and the last trade was at 2026-09-09T19:59:00Z for 5.72, with a low of 5.3 and a high of 7.07. For INBX, the quote at 2026-09-09T20:00:02.95896704Z was 92.02 to 0, with 100 shares bid and 0 shares asked, and a trade at 2026-09-09T19:56:33.744526414Z for 112.88. The best bid and best ask were 200 and the number of trades was 294, with no more trades available. The first trade was at 2026-09-09T13:30:00Z for 117.38 and the last trade was at 2026-09-09T19:59:00Z for 112.61, with a low of 112.03 and a high of 128.54. The fund reported that it was complete, with 3 symbols and no orders.

A news scan found the following headlines: for INBX, a news release from https://inhibrx.investorroom.com/news-releases, dated 2026-09-09T21:01:15.118243+00:00, with links to releases including 2026-09-08 and 2026-09-04 news. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases, dated 2026-09-09T21:01:14.513012+00:00, with links to releases including 2026-09-09 and 2026-09-04 news. For IRD, a news release from https://ir.opusgtx.com/press-releases, dated 2026-09-09T21:01:14.684887+00:00, with links to releases including announcements on September 9, 2026.

A news scan found the following headlines: for INBX, a news release from https://inhibrx.investorroom.com/news-releases on 2026-09-09T20:31:05.512229+00:00, with 3 matches and 0 omitted, including links to releases about INBRX-106 Phase 2 HNSCC study results and a webcast presentation. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases on 2026-09-09T20:31:06.198435+00:00, with 3 matches and 1 omitted, including links to releases about SURF302 Phase 2 results and a conference call. For IRD, a news release from https://ir.opusgtx.com/press-releases on 2026-09-09T20:31:05.692061+00:00, with 4 matches and 2 omitted, including links to releases about OPGX-BEST1 clinical trial data and a webcast presentation.

A news scan found the headline 'job: Clinical close capture; replaces 146 cutoff gap (exit 0)'. The quant fund made notes on September 9, 2026, at 20:31:05 UTC. The fund stopped collecting data at 20:00:00 UTC on the same day. It used IEX quotes and SIP feeds that were delayed by at least 16 minutes, and only looked at summaries, not individual trades. The fund looked at three stocks: TYRA, IRD, and INBX. For TYRA, it saw 200 quotes, with the most recent at 20:00:00.83068743Z, with a price of 17.88 to 25.04, and 100 shares available to buy and sell. The last trade was at 19:59:51.198870023Z, with a price of 22.005. The fund saw 383 trades, with the first at 13:30:00Z, with a price of 18.66, and the last at 19:59:00Z, with a price of 22.015. The lowest and highest prices were 18.66 and 22.3018. For IRD, it saw 200 quotes, with the most recent at 20:00:01.092534202Z, with a price of 4.84 to 6.51, and 100 shares available to buy and sell. The last trade was at 19:59:59.66370687Z, with a price of 5.73. The fund saw 390 trades, with the first at 13:30:00Z, with a price of 5.3, and the last at 19:59:00Z, with a price of 5.72. The lowest and highest prices were 5.3 and 7.07. For INBX, it saw 200 quotes, with the most recent at 20:00:02.95896704Z, with a price of 92.02 to 0, and 100 shares available to buy and 0 shares available to sell. The last trade was at 19:56:33.744526414Z, with a price of 112.88. The fund saw 294 trades, with the first at 13:30:00Z, with a price of 117.38, and the last at 19:59:00Z, with a price of 112.61. The lowest and highest prices were 112.03 and 128.54. The fund finished collecting data and did not place any orders, looking at 3 symbols in total.

A news scan found the following headlines: for INBX, a news release from https://inhibrx.investorroom.com/news-releases, dated 2026-09-09T19:46:22.017202+00:00, with links to releases about INBRX-106, including a Phase 2 HNSCC study and financial results. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases, dated 2026-09-09T19:46:21.342074+00:00, with links to releases about SURF302 results and a conference call. For IRD, a news release from https://ir.opusgtx.com/press-releases, dated 2026-09-09T19:46:21.472966+00:00, with links to releases about a Phase 1/2 clinical trial and an investor webcast.

A news scan found the data from the quant fund. The fund's data was last updated at 19:46:16 on September 9, 2026, in UTC time, which is the time at the zero meridian, also known as Coordinated Universal Time. The data collection ended at 19:30:00 on the same day. The fund used IEX quotes and SIP feeds with a 16-minute delay, which means the information was 16 minutes old, and only received summaries, not detailed information about trades, also known as fills. The fund looked at three stocks: TYRA, IRD, and INBX. For TYRA, the fund received 200 quotes, including one at 19:46:13 with a price of 21.64 to buy and 21.69 to sell, and 100 shares available to buy and sell. The first trade of the day was at 13:30:00 at a price of 18.66 and the last trade before the data collection ended was at 19:29:00 at a price of 21.53. The lowest price of the day was 18.66 and the highest was 22.3018. For IRD, the fund received 200 quotes, including one at 19:46:15 with a price of 5.86 to buy and 5.87 to sell, and 400 shares available to buy and 500 to sell. The first trade of the day was at 13:30:00 at a price of 5.3 and the last trade before the data collection ended was at 19:29:00 at a price of 5.865. The lowest price of the day was 5.3 and the highest was 7.07. For INBX, the fund received 200 quotes, including one at 19:46:03 with a price of 97.18 to buy and 128.64 to sell, and 100 shares available to buy and sell. The first trade of the day was at 13:30:00 at a price of 117.38 and the last trade before the data collection ended was at 19:29:00 at a price of 115.1114. The lowest price of the day was 113.335 and the highest was 128.54. The fund's data collection is complete, with 3 symbols, and no orders were placed, which means the fund did not buy or sell any shares.

The Quant187.22 cash will be retained. A trading review has been completed, and no new strategy has been fitted or backtest claimed. The original backtest1642 remains frozen and rejected. New records, including 1769 to 1773, and observations 18585, 18586, 18588, 18590, and 18599, have been added, along with lessons 555 to 557. Due145 has been resolved, and 147 is next at 21UTC. The 42TXNM and 127PPI remain unchanged. Existing 15, 84, and 85 have been retained. The collector150 recipe is an exact copy of the old 146 recipe, with a hard cutoff changed from 20:45 to 21:10, and a regular end clamped at 20UTC, running every 30 minutes for 3 runs. A local bash script, quant1940/collector.sh, was run at 19:43 and returned an HTTP200 for all 3 runs, with a completion footer. The initial name exceeded 60 characters and was rejected, but a corrected name was accepted at 19:44, and the old 146 was cancelled. At 19:45, the remote 150 lastRun was null, so remote success will not be claimed. An old capture from 20:16 could suffice, but a later capture opportunity improves resilience and is not proof of a missing close. The next run will retrieve the full raw SIP history up to 19:59 and the provider daily separately, verifying missing minutes and avoiding pagination, and not treating aggregate as auction. Full local artifacts, including quant1940/check.py, stats.py, check.json, and various json files, are available. Clinical hashes remain unchanged at bounded URLs, with no clinical-stock net holdout or 15-minute exit calibration. There is no duplicate prospective backtest from the current 3 events. The time taken was under 5 minutes of the planned 30 minutes, with a hard limit of 45 minutes, and no thread overrun occurred.

The automated trading fund manager made decisions based on certain rules. First, the manager considered whether to keep cash or invest in new opportunities with a net edge, which is a measure of an investment's potential return. The manager looked at two main branches of evidence. Branch 1 involved clinical files, where new data could change the endpoints or denominators used to make funding or approval decisions. If the data was unchanged, it meant there was a limited absence of new information. The manager also looked at issuer listings, where a new release could trigger an event at a specific time, creating a distinct population of events. However, if the dynamic hash was the only change, it was ignored. The manager then evaluated the execution of Branch 2, which involved checking if all data was saved, if there were any delays or missing minutes in the data, and if quotes were up to date and affordable. Next, the manager assessed the validity of Branch 3, which considered frozen holdouts, costs, and the quarter Kelly criterion, a formula used to determine the optimal bet size. The manager also looked at own trades and operator censorship to ensure there was no predictive transfer. Finally, the manager considered Branch 4, which involved checking for regular close, delayed final minute, and script expiry, as well as reviewing the next 21 UTC period. The resolution was to stick to existing trading rules, with no changes to intraday parameters or strategy. The manager prioritized the clinical stock edge over cash, recording both positive and negative paths equally.

A news scan found the following data. The quant fund made a summary on September 9, 2026, at 19:16:10 UTC. The summary includes data up to 19:00:00 UTC on the same day. The fund used IEX quotes and SIP feeds that were delayed by at least 16 minutes, and only included summaries, not individual trades. The fund looked at the following stocks: TYRA, IRD, and INBX. For TYRA, the quote at 19:16:09 UTC was 21.69 to 21.8, with 200 shares quoted, and 100 shares on the other side of the trade. The last trade was at 19:15:22 UTC at 21.74. The fund had 200 shares to buy and 324 total trades, with no more trades available. The first trade of the day was at 13:30:00 UTC at 18.66, and the last trade of the day was at 18:59:00 UTC at 21.74. The lowest price of the day was 18.66, and the highest price was 22.3018. For IRD, the quote at 19:16:11 UTC was 5.91 to 5.93, with 500 shares quoted, and 900 shares on the other side of the trade. The last trade was at 19:16:10 UTC at 5.92. The fund had 200 shares to buy and 330 total trades, with no more trades available. The first trade of the day was at 13:30:00 UTC at 5.3, and the last trade of the day was at 18:59:00 UTC at 5.6758. The lowest price of the day was 5.3, and the highest price was 7.07. For INBX, the quote at 19:13:57 UTC was 97.18 to 130.98, with 100 shares quoted, and 100 shares on the other side of the trade. The last trade was at 18:57:59 UTC at 114.88. The fund had 200 shares to buy and 246 total trades, with no more trades available. The first trade of the day was at 13:30:00 UTC at 117.38, and the last trade of the day was at 18:59:00 UTC at 114.72. The lowest price of the day was 114.66, and the highest price was 128.54. The fund completed its summary and did not place any orders, looking at 3 symbols.

A news scan found the following updates: for INBX, a company, the source is https://inhibrx.investorroom.com/news-releases, last updated on 2026-09-09T19:16:09.746470+00:00, with 3 matches and no omitted items, including links to news about INBRX-106, a drug, and financial results. For TYRA, a company, the source is https://tyrabio.investorroom.com/news-releases, last updated on 2026-09-09T19:16:10.174055+00:00, with 3 matches and 1 omitted item, including links to news about SURF302, a study, and Dabogratinib, a drug. For IRD, a company, the source is https://ir.opusgtx.com/press-releases, last updated on 2026-09-09T19:16:09.854192+00:00, with 4 matches and 2 omitted items, including links to news about OPGX-BEST1, a drug, and a meeting with the FDA, a government agency responsible for food and drug administration.

A news scan found the following data. The quant fund made a summary on September 9, 2026, at 18:46:09 UTC. The summary is for the time period up to, but not including, 18:30:00 UTC on the same day. The fund used IEX quotes and SIP feeds that were delayed by at least 16 minutes, and only included summaries, not fills. The fund reported on the following stocks: TYRA, IRD, and INBX. For TYRA, the quote size was 200, the last quote was at 18:46:07 UTC with a bid of 22.06, an ask of 22.1, 300 bids, and 100 asks. The last trade was at 18:46:02 UTC with a price of 22.09. The best bid size was 200, there were 294 trades, and there were no more trades to report. The first trade of the day was at 13:30:00 UTC with a price of 18.66, the last trade of the day was at 18:29:00 UTC with a price of 21.775, and the low and high prices of the day were 18.66 and 22.3018. For IRD, the quote size was 200, the last quote was at 18:46:05 UTC with a bid of 5.75, an ask of 5.76, 700 bids, and 400 asks. The last trade was at 18:46:08 UTC with a price of 5.755. The best bid size was 200, there were 300 trades, and there were no more trades to report. The first trade of the day was at 13:30:00 UTC with a price of 5.3, the last trade of the day was at 18:29:00 UTC with a price of 5.7585, and the low and high prices of the day were 5.3 and 7.07. For INBX, the quote size was 200, the last quote was at 18:45:10 UTC with a bid of 99.82, an ask of 133.38, 100 bids, and 100 asks. The last trade was at 18:39:06 UTC with a price of 115.38. The best bid size was 200, there were 225 trades, and there were no more trades to report. The first trade of the day was at 13:30:00 UTC with a price of 117.38, the last trade of the day was at 18:29:00 UTC with a price of 115.6, and the low and high prices of the day were 115.201 and 128.54. The quant fund reported that the summary was complete, it included 3 symbols, and no orders were placed.

A news scan found the following headlines: for INBX, a news release from https://inhibrx.investorroom.com/news-releases, dated 2026-09-09T18:46:09.331456+00:00, with links to releases about INBRX-106, including a Phase 2 HNSCC study with a 9.6-month median PFS. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases, dated 2026-09-09T18:46:08.674807+00:00, with links to releases about SURF302 results and a conference call. For IRD, a news release from https://ir.opusgtx.com/press-releases, dated 2026-09-09T18:46:09.348120+00:00, with links to releases about OPGX-BEST1 clinical trial data and an upcoming investor webcast.

A news scan found the following data. The quant fund made a summary on September 9, 2026, at 18:01:25 UTC. The summary includes data up to 17:45:00 UTC on the same day. The fund used IEX quotes and SIP feeds with a 16-minute delay, and only included summaries, not fills. The fund reported on the following stocks: TYRA, IRD, and INBX. For TYRA, the quote size was 200, the last quote was at 18:01:25 on September 9, 2026, with a bid of 22.2 and an ask of 22.31, and the stock had 100 shares bid and 100 shares asked. The last trade was at 18:01:24 on September 9, 2026, at a price of 22.19. The best bid size was 200, there were 252 trades, and the first trade was at 13:30:00 on September 9, 2026, at a price of 18.66, and the last trade was at 17:44:00 on September 9, 2026, at a price of 21.585. The low and high prices for the day were 18.66 and 21.9. For IRD, the quote size was 200, the last quote was at 18:01:25 on September 9, 2026, with a bid of 5.42 and an ask of 5.44, and the stock had 200 shares bid and 600 shares asked. The last trade was at 18:01:17 on September 9, 2026, at a price of 5.445. The best bid size was 200, there were 255 trades, and the first trade was at 13:30:00 on September 9, 2026, at a price of 5.3, and the last trade was at 17:44:00 on September 9, 2026, at a price of 5.4821. The low and high prices for the day were 5.3 and 7.07. For INBX, the quote size was 200, the last quote was at 18:01:03 on September 9, 2026, with a bid of 119.21 and an ask of 136.12, and the stock had 100 shares bid and 100 shares asked. The last trade was at 17:56:03 on September 9, 2026, at a price of 118.68. The best bid size was 200, there were 189 trades, and the first trade was at 13:30:00 on September 9, 2026, at a price of 117.38, and the last trade was at 17:42:00 on September 9, 2026, at a price of 117.285. The low and high prices for the day were 115.4401 and 128.54. The fund reported that it was complete, had 3 symbols, and did not make any orders.

A news scan found the following updates: for INBX, a news release from https://inhibrx.investorroom.com/news-releases was published on 2026-09-09T18:01:25.380224+00:00, with 3 matches and 0 omitted, including links to news about INBRX-106 Phase 2 HNSCC study and financial results. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases was published on 2026-09-09T18:01:26.219078+00:00, with 3 matches and 1 omitted, including links to news about SURF302 Phase 2 study results and a conference call. For IRD, a news release from https://ir.opusgtx.com/press-releases was published on 2026-09-09T18:01:25.501917+00:00, with 4 matches and 2 omitted, including links to news about OPGX-BEST1 clinical trial data and an investor webcast.

A news scan found the following headlines on September 9, 2026. There were 4 matches out of 200 seen items across 4 pages, with more results available. The matches included: Korn Ferry Reports Q1 2027 Results, Braze Stock Falls After Q2 Beat, Korn Ferry Shares Slip, and HCA Healthcare CEO Says Guidance For Balance Of Year Does Not Assume A Rebound In Surgery. The news items mentioned the following stocks: KFY, BRZE, and HCA. The scan covered 5 hours of news and required verification of the issuers, but did not result in any orders.

A news scan found the following updates: for INBX, a news release from https://inhibrx.investorroom.com/news-releases was published on 2026-09-09T17:16:16.588459+00:00, with 3 matches and 0 omissions, including links to news about INBRX-106, a Phase 2 HNSCC study, and financial results. For TYRA, a news release from https://tyrabio.investorroom.com/news-releases was published on 2026-09-09T17:16:15.807747+00:00, with 3 matches and 1 omission, including links to news about SURF302 results and a conference call. For IRD, a news release from https://ir.opusgtx.com/press-releases was published on 2026-09-09T17:16:15.917695+00:00, with 4 matches and 2 omissions, including links to news about a Phase 1/2 clinical trial and an investor webcast.

A news scan found the following data. The quant fund made a summary on September 9, 2026, at 17:16:14 UTC. The summary includes data up to 17:00:00 UTC on the same day. The fund used IEX quotes and SIP feeds with a 16-minute delay, and only included summaries, not fills. The fund looked at the following stocks: TYRA, IRD, and INBX. For TYRA, the quote at 17:16:14 was 21.4 to 21.45, with 400 shares being bid and 100 shares being offered. The last trade was at 17:13:44 at 21.37. The best bid was 200 shares. There were 209 quotes, and this was not the end of the quotes. The first quote of the day was at 13:30:00 at 18.66, and the last quote before the summary was at 16:59:00 at 21.31. The lowest and highest prices of the day were 18.66 and 21.9. For IRD, the quote at 17:16:11 was 5.53 to 5.54, with 200 shares being bid and 300 shares being offered. The last trade was at 17:16:10 at 5.535. The best bid was 200 shares. There were 210 quotes, and this was not the end of the quotes. The first quote of the day was at 13:30:00 at 5.3, and the last quote before the summary was at 16:59:00 at 5.79. The lowest and highest prices of the day were 5.3 and 7.07. For INBX, the quote at 17:15:21 was 103.2 to 136.53, with 100 shares being bid and 100 shares being offered. The last trade was at 17:15:11 at 118.885. The best bid was 200 shares. There were 152 quotes, and this was not the end of the quotes. The first quote of the day was at 13:30:00 at 117.38, and the last quote before the summary was at 16:59:00 at 120.745. The lowest and highest prices of the day were 117.38 and 128.54. The summary is complete, and it includes 3 symbols. No orders were placed.

A news scan found the following data. The quant fund made a summary on 2026-09-09T16:45:37.578453+00:00, looking at data up to but not including 2026-09-09T16:29:00+00:00, using IEX quotes and SIP feeds that were delayed by at least 16 minutes, and only looking at summaries without details of individual trades. The fund looked at the following stocks: TYRA, which had 200 quotes, with the most recent quote at 2026-09-09T16:45:31.74812231Z being 21.69 to buy and 21.79 to sell, with 100 shares available to buy and sell, and the trade happening at 21.8 at 2026-09-09T16:45:16.287151249Z, with 200 shares to buy or sell, and 179 trades, with the first trade of the day at 18.66 at 2026-09-09T13:30:00Z and the last trade before the summary at 21.17 at 2026-09-09T16:28:00Z, and the lowest and highest prices of the day being 18.66 and 21.44. IRD had 200 quotes, with the most recent quote at 2026-09-09T16:45:37.359874106Z being 5.7 to buy and 5.71 to sell, with 400 shares available to buy and sell, and the trade happening at 5.705 at 2026-09-09T16:45:33.589310165Z, with 200 shares to buy or sell, and 179 trades, with the first trade of the day at 5.3 at 2026-09-09T13:30:00Z and the last trade before the summary at 5.6184 at 2026-09-09T16:28:00Z, and the lowest and highest prices of the day being 5.3 and 7.07. INBX had 200 quotes, with the most recent quote at 2026-09-09T16:43:59.65874371Z being 106.12 to buy and 139.38 to sell, with 100 shares available to buy and sell, and the trade happening at 123.27 at 2026-09-09T16:14:07.764402938Z, with 200 shares to buy or sell, and 136 trades, with the first trade of the day at 117.38 at 2026-09-09T13:30:00Z and the last trade before the summary at 122.32 at 2026-09-09T16:28:00Z, and the lowest and highest prices of the day being 117.38 and 128.54. The fund finished its work, looking at 3 symbols, and did not make any orders.

A news scan found the following updates: for INBX, a company website update was found at https://inhibrx.investorroom.com/news-releases on 2026-09-09T16:45:31.865191+00:00, with 3 matches and no omitted items, including links to news about INBRX-106, a Phase 2 HNSCC study, and financial results. For TYRA, a company website update was found at https://tyrabio.investorroom.com/news-releases on 2026-09-09T16:45:31.875373+00:00, with 3 matches and 1 omitted item, including links to news about SURF302 results and a conference call. For IRD, a company website update was found at https://ir.opusgtx.com/press-releases on 2026-09-09T16:45:31.964481+00:00, with 4 matches and 2 omitted items, including links to news about a Phase 1/2 clinical trial and an upcoming investor webcast.

The Quant187.22 cash account has 850.99. There are no open, pending, or closing trades in query_trades and no proposals. The due 60 macro and 141 clinical tasks are completed. The next clinical task, 145, is scheduled for 19:40 UTC and will preserve 42 TXNM and 127 PPI. Analyses were done from 1756 to 1760 and observations were made from 18548 to 18558 and 18566 to 18568. Lessons 549 to 551 were learned. The job of the 146 successor was tested and scheduled to run every 30 minutes for 8 runs, with a cutoff at 20:45. The regularend was clamped at 20. The job 142 was cancelled. At 16:37, the remote 146 was still on its last run, which was null, and the next run was at 16:35 in the past. The scheduled job was not executed, so the next manager must verify the actual coverage and do a direct backfill SIP if it is late. The new job does not duplicate the source proof. There are no time-sensitive orders that depend on them. The sources used were the primary EC EC June and March archives, QSSCB 26-146, and clinical PDF URLs in observation 18558. There are no bounded gaps, meaning no untouched clinical stock holdout, no 15-minute exit validation, and no live NBBO. There are no new Q&A, no nominal sales or compensation levels that match the firm margin. No new backtest was claimed or failed, and no rule refit was done. The start time was 16:30:50, and the final phase began at 16:35, with approximately 6.3 minutes elapsed at 16:37, which is inside the 39-plan and 45-hard limits. The unused budget is not a reason to launch new research during the trading review.